A rapid in situ procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis

BACKGROUND: Antibiotics which inhibit bacterial peptidoglycan biosynthesis are the most widely used in current clinical practice. Nevertheless, resistant strains increase dramatically, with serious economic impact and effects on public health, and are responsible for thousands of deaths each year. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Santiso, Rebeca, Tamayo, María, Gosálvez, Jaime, Bou, Germán, Fernández, María del Carmen, Fernández, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Methodology Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179955/
https://www.ncbi.nlm.nih.gov/pubmed/21867549
http://dx.doi.org/10.1186/1471-2180-11-191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179955/
https://www.ncbi.nlm.nih.gov/pubmed/21867549
http://dx.doi.org/10.1186/1471-2180-11-191

Ejemplares similares